Five-Pillar Analysis for UTHR
TopTier Strategy breaks every stock down into five clear pillars — so you can quickly see what makes United Therapeutics Corporation a strong or weak investment candidate.
Is UTHR priced fairly?
P/E, EV/EBITDA, P/B, and free cash flow yield — versus sector medians and UTHR's own history. Our valuation engine flags whether United Therapeutics Corporation is trading rich, fair, or cheap.
How efficient is United Therapeutics Corporation?
Gross margin, operating margin, net margin — and how they're trending. Stable or expanding margins signal pricing power; declining margins are an early warning.
Can UTHR survive a downturn?
Debt-to-equity, current ratio, quick ratio, and interest coverage. We screen United Therapeutics Corporation's balance sheet for stress and flag liquidity or leverage risk.
What's UTHR earning on capital?
Return on Equity, Return on Invested Capital, and Return on Assets. We compare United Therapeutics Corporation's capital efficiency to peers — and check leverage to make sure ROE isn't financial-engineering noise.
Is United Therapeutics Corporation expanding?
Revenue growth, EPS growth, and free cash flow growth — over 1, 3, and 5 years. We separate genuine operating growth from buyback-driven EPS gains.
See the complete UTHR breakdown
Sign up free to unlock United Therapeutics Corporation's full five-pillar analysis with live financial data, peer comparisons, and historical context.
Frequently Asked Questions about UTHR
Quick answers to the most common questions about United Therapeutics Corporation.
What does United Therapeutics Corporation (UTHR) do?
How do I analyze UTHR stock?
Is UTHR a good stock to buy?
Where can I see UTHR's financial data?
Popular Stocks
Other widely-followed stocks investors research on TopTier Strategy.
See UTHR's full five-pillar analysis
Free account. 5 stock searches per day. No credit card required.
Sign Up Free